Skip to main content
Caplight Logo









Fay

Fay

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.faynutrition.com/

Last Round

Series B

Mar 26, 2026

Est. Valuation

$500M

Total Funding Raised

$130M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Fay is a digital health company that operates a vertical AI platform connecting individuals with registered dietitians for personalized, insurance-covered nutrition and lifestyle counseling.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Vertical SaaS

Business Model

B2B2C

Customer Profile

Services & Consulting, Marketplace Commission

AI Layer

Application

Keywords

nutrition counselingregistered dietitiandietitian marketplacetelehealthnutritionist findermedical nutrition therapyinsurance billingpractice managementcare coordinationdigital healthhealth techvertical SaaSRCMrevenue cycle managementmanagement services organizationMSO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fay Comparables

Compare Fay with similar companies based on industry and business-model similarity.

Fay comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Berry Street
93%
Nourish
90%
Culina Health
82%

Fay Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 26, 2026
Series BFeb 5, 2025
Series AMay 15, 2024
SeedMay 15, 2023
SeedJan 1, 2023

Key People

Founding team and executive leadership

Sam Faycurry

Co-Founder CEO

Founding Team

Fay Investors

Notable investors and investment history

Fay investors
InvestorRounds
Forerunner VenturesSeries B, Series A
Goldman Sachs (Asia) LLCSeries B
Goldman Sachs Growth EquitySeries B
General CatalystSeries A, Series B, Seed
1984 VenturesSeries A
Goldman SachsSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2026

    $50M Series B round completed.

  • Mar 1, 2026

    Works with Aetna, BCBS, Cigna, UHC, Humana, Medicare, and Medicaid.

Fay Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fay Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fay's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range472
Year Founded2022
Last FundingMar 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?